Why it was recalled
Crystallization
Product description
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
Lot numbers, UPCs & expiration codes
Lot #: T400512, Exp 02/28/2026
Where it was sold
NY
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0011-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Sep 24, 2024
- FDA report date
- Oct 23, 2024
- Quantity
- 2544 pumps
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- VIONA PHARMACEUTICALS INC
Original FDA data
Every field from FDA enforcement report D-0011-2025, exactly as published.
Show all FDA fields
- City
- Cranford
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 95412
- Address
- 20 Commerce Dr Ste 340
- Code information
- Lot #: T400512, Exp 02/28/2026
- Postal code
- 07016-3617
- Report date
- Oct 23, 2024
- Product type
- Drugs
- Recall number
- D-0011-2025
- Classification
- Class II
- Recalling firm
- VIONA PHARMACEUTICALS INC
- Product quantity
- 2544 pumps
- Reason for recall
- Crystallization
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
- Distribution pattern
- NY
- Recall initiation date
- Sep 24, 2024
- Center classification date
- Oct 12, 2024